Candidal meningitis
ICD-10 B40.1 is a billable code used to indicate a diagnosis of candidal meningitis.
Candidal meningitis is a rare but serious fungal infection of the central nervous system caused by Candida species, most commonly Candida albicans. This condition typically occurs in immunocompromised patients, such as those with HIV/AIDS, cancer, or those undergoing immunosuppressive therapy. The infection can manifest as a result of hematogenous spread from other sites of infection, particularly in patients with a history of candidemia. Symptoms may include fever, headache, neck stiffness, altered mental status, and other neurological deficits. Diagnosis is confirmed through lumbar puncture and analysis of cerebrospinal fluid (CSF), which may show elevated white blood cell counts, low glucose levels, and the presence of Candida organisms. Treatment involves the use of antifungal agents, such as amphotericin B or fluconazole, and may require prolonged therapy depending on the severity of the infection and the patient's immune status. Early recognition and treatment are crucial to improve outcomes in affected patients.
Detailed history of immunocompromised conditions, lab results, and treatment plans.
Patients with HIV/AIDS presenting with neurological symptoms.
Ensure all relevant lab results and treatment responses are documented.
Neurological examination findings, imaging results, and CSF analysis.
Patients with altered mental status and signs of meningitis.
Document differential diagnoses and rationale for testing.
Used to obtain CSF for analysis in suspected meningitis cases.
Document indication for procedure and CSF analysis results.
Neurology and Infectious Disease specialists should ensure thorough documentation.
Common symptoms include fever, headache, neck stiffness, altered mental status, and neurological deficits.
Diagnosis is made through lumbar puncture and analysis of cerebrospinal fluid, which may show elevated white blood cell counts and the presence of Candida species.
